These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3279723)

  • 21. Comparison of different insulin regimens in elderly patients with NIDDM.
    Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.
    Alvarsson M; Sundkvist G; Lager I; Henricsson M; Berntorp K; Fernqvist-Forbes E; Steen L; Westermark G; Westermark P; Orn T; Grill V
    Diabetes Care; 2003 Aug; 26(8):2231-7. PubMed ID: 12882841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus.
    Lindström T; Nyström FH; Olsson AG; Ottosson AM; Arnqvist HJ
    Diabet Med; 1999 Oct; 16(10):820-6. PubMed ID: 10547208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients.
    Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC
    Diabet Med; 2004 Apr; 21(4):349-53. PubMed ID: 15049937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
    Nauck MA; Weber I; Bach I; Richter S; Orskov C; Holst JJ; Schmiegel W
    Diabet Med; 1998 Nov; 15(11):937-45. PubMed ID: 9827848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
    Osei K; O'Dorisio TM; Falko JM
    Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycaemic responsiveness to long-term insulin plus sulphonylurea therapy as assessed by sulphonylurea withdrawal.
    Nybäck-Nakell A; Adamson U; Lins PE; Landstedt-Hallin L
    Diabet Med; 2007 Dec; 24(12):1424-9. PubMed ID: 17976204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
    Simpson HC; Sturley R; Stirling CA; Reckless JP
    Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.
    Emanuele N; Azad N; Abraira C; Henderson W; Colwell J; Levin S; Nuttall F; Comstock J; Sawin C; Silbert C; Marcovina S; Lee HS
    Arch Intern Med; 1998 Dec 7-21; 158(22):2485-90. PubMed ID: 9855387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A; Schmülling RM; Häring HU; Stumvoll M
    Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus.
    Kökoğlu E; Ulakoğlu E
    Diabetes Res Clin Pract; 1991 Dec; 14(3):175-81. PubMed ID: 1778110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control.
    Jain SK; Nagi DK; Slavin BM; Lumb PJ; Yudkin JS
    Diabet Med; 1993; 10(1):27-32. PubMed ID: 8435984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
    Laakso M; Sarlund H; Ehnholm C; Voutilainen E; Aro A; Pyörälä K
    Diabetologia; 1987 Sep; 30(9):703-6. PubMed ID: 3428502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients.
    Vessby B; Boberg M; Hellsing K; Lithell H; Berne C
    Diabetes Res; 1989 Nov; 12(3):109-16. PubMed ID: 2699585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of duration of type 2 diabetes mellitus on insulin secretion.
    Zangeneh F; Arora PS; Dyck PJ; Bekris L; Lernmark A; Achenbach SJ; Oberg AL; Rizza RA
    Endocr Pract; 2006; 12(4):388-93. PubMed ID: 16939949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.
    Giugliano D; Quatraro A; Consoli G; Minei A; Ceriello A; De Rosa N; D'Onofrio F
    Eur J Clin Pharmacol; 1993; 44(2):107-12. PubMed ID: 8453955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
    Garg A; Grundy SM; Koffler M
    Diabetes Care; 1992 Nov; 15(11):1572-80. PubMed ID: 1468287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
    Farrer M; Winocour PH; Evans K; Neil HA; Laker MF; Kesteven P; Alberti KG
    Diabetes Res Clin Pract; 1994 Mar; 23(2):111-9. PubMed ID: 8070302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.